Annotations: 1ZLG

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	F_UNCLASSIFIED	e1zlgA5	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: Immunoglobulin-related	T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like	F: F_UNCLASSIFIED	ECOD (1.6)
A	PF00041	e1zlgA4	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: Immunoglobulin-related	T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like	F: PF00041	ECOD (1.6)
A	PF00095	e1zlgA2	A: few secondary structure elements	X: Elafin-like (From Topology)	H: Elafin-like (From Topology)	T: Elafin-like	F: PF00095	ECOD (1.6)
A	PF17869	e1zlgA1	A: few secondary structure elements	X: Anosmin 1 N-terminal cysteine-rich domain (From Topology)	H: Anosmin 1 N-terminal cysteine-rich domain (From Topology)	T: Anosmin 1 N-terminal cysteine-rich domain	F: PF17869	ECOD (1.6)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00095	WAP-type (Whey Acidic Protein) 'four-disulfide core' (WAP)	WAP-type (Whey Acidic Protein) 'four-disulfide core'	WAP belongs to the group of Elafin or elastase-specific inhibitors.	Domain
A	PF00041	Fibronectin type III domain (fn3)	Fibronectin type III domain	-	Domain
A	PF17869	Anosmin cysteine rich domain (Cys_box)	Anosmin cysteine rich domain	This is the Cys-box (cysteine-rich) domain found on the N-terminal of anosmin-1 proteins. It is suggested that the Cys-box domain may resemble the cysteine-rich region of the insulin-like growth factor receptor [1]. Family members are found in chorda ...	This is the Cys-box (cysteine-rich) domain found on the N-terminal of anosmin-1 proteins. It is suggested that the Cys-box domain may resemble the cysteine-rich region of the insulin-like growth factor receptor [1]. Family members are found in chordates.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Anosmin 1	enzyme regulator activity molecular function inhibitor activity peptidase regulator activity serine-type endopeptidase inhibitor activity molecular function regulator activity enzyme inhibitor activity peptidase inhibitor activity endopeptidase regulator activity endopeptidase inhibitor activity structural molecule activity extracellular matrix structural constituent heparin binding glycosaminoglycan binding binding enzyme regulator activity molecular function inhibitor activity peptidase regulator activity serine-type endopeptidase inhibitor activity molecular function regulator activity enzyme inhibitor activity peptidase inhibitor activity endopeptidase regulator activity endopeptidase inhibitor activity structural molecule activity extracellular matrix structural constituent heparin binding glycosaminoglycan binding binding carbohydrate derivative binding sulfur compound binding	chemotaxis response to stimulus taxis response to chemical response to external stimulus locomotion multicellular organismal process axonogenesis cellular developmental process cell projection organization plasma membrane bounded cell projection morphogenesis cell development neuron projection development cell morphogenesis chemotaxis response to stimulus taxis response to chemical response to external stimulus locomotion multicellular organismal process axonogenesis cellular developmental process cell projection organization plasma membrane bounded cell projection morphogenesis cell development neuron projection development cell morphogenesis cellular component organization neurogenesis multicellular organism development cell projection morphogenesis neuron differentiation neuron projection morphogenesis cell differentiation anatomical structure development cellular component organization or biogenesis system development developmental process plasma membrane bounded cell projection organization axon guidance nervous system development axon development cell morphogenesis involved in neuron differentiation generation of neurons anatomical structure morphogenesis neuron projection guidance neuron development cellular process cell adhesion	extracellular region cellular anatomical entity cell surface cell periphery plasma membrane membrane extracellular matrix external encapsulating structure extracellular space

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR003961	Fibronectin type III	Domain
A	IPR040957	Anosmin-1, cysteine rich domain	Domain
A	IPR036645	Elafin-like superfamily	Homologous Superfamily
A	IPR013783	Immunoglobulin-like fold	Homologous Superfamily
A	IPR042447	Anosmin-1	Family
A	IPR008197	WAP-type 'four-disulfide core' domain	Domain
A	IPR036116	Fibronectin type III superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: P23352	Kallmann syndrome hypogonadotropic hypogonadism 1 with or without anosmia non-small cell lung carcinoma pituitary cancer astrocytic tumor hypogonadism hypogonadotropic hypogonadism 2 with or without anosmia large cell medulloblastoma lung cancer malignant pancreatic neoplasm ovarian cancer progressive supranuclear palsy congenital anomaly of kidney and urinary tract hypogonadotropic hypogonadism Idiopathic Hypogonadotropic Hypogonadism Kallmann syndrome hypogonadotropic hypogonadism 1 with or without anosmia non-small cell lung carcinoma pituitary cancer astrocytic tumor hypogonadism hypogonadotropic hypogonadism 2 with or without anosmia large cell medulloblastoma lung cancer malignant pancreatic neoplasm ovarian cancer progressive supranuclear palsy congenital anomaly of kidney and urinary tract hypogonadotropic hypogonadism Idiopathic Hypogonadotropic Hypogonadism limb-girdle muscular dystrophy lung carcinoma medulloblastoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia sinusitis cystic fibrosis interstitial cystitis Klinefelter syndrome lung adenocarcinoma malignant colon neoplasm

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.